The interplay of dietary mycotoxins and oncogenic viruses toward human carcinogenesis: a scoping review

Thanos Mouchtaris Michailidis1,2,3, Sarah De Saeger1,2,4, Rita Khoueiry3

  • 1Faculty of Pharmaceutical Sciences, Centre of Excellence in Mycotoxicology and Public Health, Ghent University, Ghent, Belgium.

Abstract

Insights

Mycotoxins like aflatoxin B1 (AFB1) significantly increase cancer risk when combined with oncogenic viruses. This synergistic effect is notable for hepatitis viruses in liver cancer and warrants further investigation for HPV and EBV.

Area of Science:

  • Toxicology
  • Oncology
  • Virology

Background:

  • Mycotoxins are fungal metabolites found in food with known carcinogenic potential.
  • Their interaction with oncogenic viruses amplifies cancer risk.

Purpose of the Study:

  • To review and synthesize evidence on human cancer risk from mycotoxin exposure and oncogenic virus infections.
  • To identify synergistic effects between mycotoxins and viruses in cancer development.

Main Methods:

  • Scoping review of studies from PubMed, Embase, and Web of Science.
  • Data extraction using the PECOS framework, with narrative and qualitative synthesis.
  • Risk of bias and outcome quality assessed using OHAT and GRADE.

Main Results:

  • Aflatoxins (AFB1) and hepatitis viruses show a significant synergistic effect in hepatocellular carcinoma (HCC).
  • AFB1 interactions with human papilloma virus (HPV) and Epstein-Barr virus (EBV) were observed but require more research.
  • 25 studies were included, with a focus on AFB1 in HCC, cervical cancer, and lymphoma.

Conclusions:

  • The combined impact of mycotoxins and oncogenic viruses poses a significant public health risk.
  • Further research, including prospective studies and molecular mechanism investigations, is crucial.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K